Study protocol: the ‘Endoscope CRC’ cohort, a prospective biobank study on the development and evaluation of diagnostic and prognostic biomarker profiles for colorectal cancer and premalignant lesions
The study is approved by the medical ethics committee at the Maastricht University Medical Center (NL74844.068.20) in November 2021 and started inclusion in January 2022.
Authors
- Robert van Vorstenbosch (ORCID: https://orcid.org/0000-0003-1953-0207)
- Erik J. Schoon (ORCID: https://orcid.org/0000-0003-4515-1235)
- Zlatan Mujagic (ORCID: https://orcid.org/0000-0001-5211-0381)
- Frederik‐Jan van Schooten (ORCID: https://orcid.org/0000-0001-8111-8198)
- Agnieszka Smolinska (ORCID: https://orcid.org/0000-0002-1412-4544)
- Daisy M.A.E. Jonkers (ORCID: https://orcid.org/0000-0001-8981-8965)
- Hao Cheng (ORCID: https://orcid.org/0000-0003-3474-1512)
- Adrian A. M. Masclee
Institutions
- Radboud University Nijmegen (NL)
- Maastricht University Medical Centre (NL)
- Catharina Ziekenhuis (NL)
- Maastricht University (NL)
Publication Details
- Journal
- BMJ Open
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1136/bmjopen-2023-083229
- Citations
- 2
- Primary Topic
- Advanced Chemical Sensor Technologies
- Type
- article
- Field-Weighted Citation Impact
- 0.37
Funders
- Pfizer
- ZonMw